380
Participants
Start Date
April 12, 2023
Primary Completion Date
September 30, 2025
Study Completion Date
December 31, 2027
Semaglutide
Subcutaneous Semaglutide, 0.5 mg weekly for 4 weeks. First dose given at inclusion.
Standard care
Treatment according to Danish national clinical guidelines on stroke treatment, including reperfusion therapy if eligible.
RECRUITING
Aarhus University Hospital, Aarhus
Bispebjerg Hospital
OTHER
Glostrup University Hospital, Copenhagen
OTHER
Odense University Hospital
OTHER
Herning Hospital
OTHER
Aalborg University Hospital
OTHER
Rigshospitalet, Denmark
OTHER
Aarhus University Hospital
OTHER